Command Palette

Search for a command to run...

vista-pharmaceuticals

9.99+0.81%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

In the Pharmaceuticals & Drugs sector, Vista Pharmaceuticals Ltd. significantly underperforms compared to its peers, exhibiting no revenue growth and negative profitability metrics. In contrast, Sun Pharmaceutical Industries Ltd. and Cipla Ltd. stand out as leaders in growth and profitability, presenting a strong case for investment. The sector shows a mix of growth and value opportunities, with several companies maintaining healthy financials despite varying valuations.

Key Points
  • Vista Pharmaceuticals Ltd. shows no growth and negative PE, indicating severe financial challenges.
  • Sun Pharmaceutical and Cipla are strong performers with significant revenue growth and profitability.
  • Divi's Laboratories exhibits high valuation metrics with declining growth, indicating potential overvaluation.
Top Performers
Sun Pharmaceutical Industries Ltd.

Strong revenue and EPS growth, high ROE, and profitability metrics.

Cipla Ltd.

Solid revenue growth, attractive PE ratio, and high ROE.

Dr. Reddy's Laboratories Ltd.

Excellent profitability metrics and manageable debt levels.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.